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A Novel Endoscopic Treatment for Blue Rubber Bleb Nevus Syndrome
Khaled Almadhoun DO, Diana Kakos MS4, Georgi Fram MD, Anas Kutait MD

Henry Ford Health System, Detroit, Michigan
Abstract
Introduction: Blue Rubber Bleb Nevus Syndrome (BRBNS), also known as Bean Syndrome, is a
congenital disorder characterized by numerous, cutaneous and internal venous malformations, most
commonly involving the skin and gastrointestinal tract (GI). (1) Patients with GI manifestations
present with iron deficiency anemia due to recurrent GI hemorrhage from the oozing venous
malformations. Due to the rarity of the condition, there are no defined guidelines on the management
of BRBNS, further highlighting the need for case reports to dictate therapy.

•
•
•
•

Case Presentation: We present a case of an 83-year-old male who presented with a GI bleed due to
an unknown etiology. Workup was initiated with an esophagogastroduodenoscopy (EGD) and a
colonoscopy. The initial colonoscopy had poor prep and difficult visualization due to excessive
bleeding. This led to extensive testing as the patient continued to have ongoing blood loss, which
included a tagged red blood cell scan, angiography with attempted embolization, and magnetic
resonance enterography. Finally, the patient was able to repeat a colonoscopy with appropriate prep,
and findings consistent with BRBNS were identified. The patient was treated with six hemoclips of the
actively bleeding spots, with resolution of his symptoms. The patient was followed for approximately
two years, and has not had recurrence of GI bleed, with a stable hemoglobin.
Discussion: Blue Rubber Bleb Nevus Syndrome (BRBNS), is a congenital disorder characterized by
numerous, cutaneous and internal venous malformations. The treatment of GI BRBNS is determined
by the severity of the disease, taking frequency and volume of hemorrhage, as well as extent of
intestinal involvement, into consideration. Treatment options include medical management with agents
such as siroliumus, endoscopic therapy with band ligation, and sclerotherapy, and surgical resection of
the affected bowel. A Pubmed/MedLINE literature review elucidated one other case of endoscopic
hemoclip as treatment for BRBNS, with the resolution of patient symptoms for 5 years. Endoscopic
hemoclipping is a successful, novel, and clearly underutilized treatment option for BRBNS as
currently there is no standard of treatment for Blue Rubber Bleb Nevus Syndrome.

Discussion

Endoscopic Photos

•
•
•
•
Figure 1. Ascending Colon with Blue
Rubber Blebs

Figure 2. Cecum with Blue Rubber Blebs

•

Introduction
• Blue Rubber Bleb Nevus Syndrome (BRBNS), also known as Bean Syndrome, is a
congenital disorder characterized by numerous, cutaneous and internal venous
malformations (VMs)
•
• VMs most commonly involve the skin and gastrointestinal (GI) tract
•

• Patients with GI manifestations present with iron deficiency anemia due to recurrent GI
hemorrhage from the oozing venous malformations
• Due to the rarity of the condition, there are no defined guidelines on the management
of BRBNS, further highlighting the need for case reports to dictate therapy

Case Presentation
• 83-year-old male presented to the emergency department (ED) with altered mental status and
urinary incontinence for 5 days, as well as melena for 3 weeks
• Patient history was significant for Abdominal Aortic Aneurysm status post endovascular repair, on
triple anticoagulation with Eliquis, Plavix, and Aspirin
• Patient was hemodynamically stable in the ED, with laboratory studies significant for a hemoglobin
of 3.9 g/dl and a positive stool guaiac test. An extensive work up was conducted.
• EGD -> Negative for acute bleeding. Colonoscopy -> Inconclusive
• Tagged Red Blood Cell Scan -> Bleeding in the right upper quadrant of the abdomen, suggestive
of an active small bowel bleed. This gave a general location of the bleed, but not a definitive source.
• Interventional Radiology attempted to embolize the bleed -> Superior mesenteric and celiac
angiogram -> Negative for bleeding and a source of bleeding
• Magnetic Resonance Enterography -> Unable to provide definitive source of bleeding, however
abnormal mucosal or wall thickening at cecal and ascending colon junction could not be
excluded
• Patient continued to have bloody bowel movements with drops in hemoglobin, requiring multiple
transfusions (Figure 5)
• Repeat colonoscopy -> Multiple small, vascular, blue raised lesions visualized from hepatic
flexure, extending into the cecum, including involvement of the ileocecal valve. (Figures 1-2)
• Six hemoclips were deployed on actively oozing lesions, achieving hemostasis (Figures 3-4)
• The patient did not have any further episodes of hematochezia after the intervention, with a stable
hemoglobin.
• The patient continues to be monitored with repeat hemoglobin, and has remained stable
around 11 g/dl

Figure 3. Cecum with Hemoclipped Blue
Rubber Blebs

Figure 4. Cecum with Hemoclipped Blue
Rubber Blebs

Laboratory Values

Figure 5. Patient Hemoglobin Trend. Hemoglobin of 3.9 at admission. Hemoglobin of 8 upon
discharge, with a subsequent stable baseline of approximately 11 throughout the past two years.

•

BRBNS is a rare disorder, with approximately 200 cases reported in the literature (2-4)
Cutaneous manifestations present at birth or early childhood
Visceral involvement tends to present in early adulthood (5)
Lesions most commonly arise in the skin and GI tract; however, they have been found in
the heart, spleen, liver, CNS, eye, thyroid, parotid gland, muscles, lungs, and bladder (68)
The most common site of GI tract involvement is the small bowel; however, lesions
may develop anywhere from the mouth to the anus
While there have been many case reports discussing treatment options for BRBNS with
GI involvement, there are no guidelines regarding the management of this condition
The treatment of GI BRBNS is determined by the severity of the disease, taking
frequency and volume of hemorrhage, as well as extent of intestinal involvement, into
consideration
Mild or intermittent GI Bleed
• Iron supplementation and blood transfusions
Severe cases
• Many medical, endoscopic and surgical approaches to treatment have been taken for
severe cases.
• Medical management
• Sirolimus (9-11)
• Angiogenesis inhibitor
• Reduces the need for blood transfusions in these patients
• Adverse drug reactions have not been observed
• Endoscopic treatment
• Polypectomy
• Band ligation
• Sclerotherapy
• Surgical
• Definitive treatment can be achieved with surgical resection of the affected
bowel
The patient described in this case achieved hemostasis for approximately two years
following placement of six hemoclips
A PubMed/MedLINE search elicited one case of treatment of BRBNS with hemoclips
• Kanai et. al describes a case of a 19-year-old patient with BRBNS who was treated
with hemoclips and remained stable for 5 years (12)
Endoscopic hemoclipping is a successful, novel, and clearly underutilized treatment
option for BRBNS as currently there is no standard of treatment for Blue
Rubber Bleb Nevus Syndrome
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